Medicina
Departamento
GlaxoSmithKline (Spain)
Madrid, EspañaPublicaciones en colaboración con investigadores/as de GlaxoSmithKline (Spain) (26)
2021
-
Correction to: REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study (Drugs, (2021), 81, 15, (1763-1774), 10.1007/s40265-021-01597-9)
Drugs
-
REal worlD Effectiveness and Safety of Mepolizumab in a Multicentric Spanish Cohort of Asthma Patients Stratified by Eosinophils: The REDES Study
Drugs, Vol. 81, Núm. 15, pp. 1763-1774
2020
-
Management of adult patients with PAH in Spain: current practice, resources, and needs (AIRE17 Study)
REC: CardioClinics, Vol. 55, Núm. 3, pp. 147-154
2013
-
Safety and treatment patterns of angiogenesis inhibitors in patients with advanced renal cell carcinoma in Spain
Expert Opinion on Drug Safety, Vol. 12, Núm. 4, pp. 455-463
2010
-
Antimicrobial resistance among respiratory pathogens in Spain: Latest data and changes over 11 years (1996-1997 to 2006-2007)
Antimicrobial Agents and Chemotherapy, Vol. 54, Núm. 7, pp. 2953-2959
2009
-
Prevalence of HLA-B*5701 in HIV-infected patients in spain (results of the epi study)
HIV Clinical Trials, Vol. 10, Núm. 1, pp. 48-51
2008
-
Cidal activity of oral third-generation cephalosporins against Streptococcus pneumoniae in relation to cefotaxime intrinsic activity
European Journal of Clinical Microbiology and Infectious Diseases, Vol. 27, Núm. 8, pp. 679-683
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
-
β-lactam activity against penicillin-resistant Streptococcus pneumoniae strains exhibiting higher amoxicillin versus penicillin minimum inhibitory concentration values: An in vitro pharmacodynamic simulation
Chemotherapy, Vol. 54, Núm. 2, pp. 84-90
2007
-
Ampicillin-resistant non-β-lactamase-producing Haemophilus influenzae in Spain: Recent emergence of clonal isolates with increased resistance to cefotaxime and cefixime
Antimicrobial Agents and Chemotherapy, Vol. 51, Núm. 7, pp. 2564-2573
-
Levofloxacin vs. azithromycin pharmacodynamic activity against S. pneumoniae and H. influenzae with decreased susceptibility to amoxicillin/clavulanic acid
Journal of Chemotherapy, Vol. 19, Núm. 6, pp. 670-672
2005
-
Geographical and ecological analysis of resistance, coresistance, and coupled resistance to antimicrobials in respiratory pathogenic bacteria in Spain
Antimicrobial Agents and Chemotherapy, Vol. 49, Núm. 5, pp. 1965-1972
-
Situación de la cefalosporina oral de tercera generación cefditoreno pivoxil en el tratamiento de la infección comunitaria del adulto
Revista Espanola de Quimioterapia, Vol. 18, Núm. 3, pp. 210-216
2004
-
Adherence, quality of life, and general satisfaction with co-formulated zidovudine, lamivudine, and abacavir on antiretroviral-experienced patients
HIV Clinical Trials, Vol. 5, Núm. 1, pp. 33-39
-
Effects of effervescent ranitidine on gastric pH: Comparison with almagate and placebo in fasting and postprandial conditions
Alimentary Pharmacology and Therapeutics, Vol. 20, Núm. 6, pp. 683-688
-
In vitro combined effect of co-amoxiclav concentrations achievable in serum after a 2000/125 mg oral dose, and polymorphonuclear neutrophils against strains of Streptococcus pneumoniae exhibiting decreased susceptibility to amoxicillin
International Journal of Antimicrobial Agents, Vol. 24, Núm. 1, pp. 79-82
-
Resistencias bacterianas y farmacodinámica como bases de la prescripción de antibióticos en infecciones respiratorias
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 22, Núm. 4, pp. 230-237
2003
-
Opsonophagocytosis versus complement bactericidal killing as effectors following Neisseria meningitidis group C vaccination
Infection, Vol. 31, Núm. 1, pp. 51-54
-
Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility
Journal of Clinical Microbiology, Vol. 41, Núm. 6, pp. 2385-2390
2002
-
Activities of six different quinolones against clinical respiratory isolates of streptococcus pneumoniae with reduced susceptibility to ciprofloxacin in Spain
Antimicrobial Agents and Chemotherapy, Vol. 46, Núm. 8, pp. 2665-2667